PTK6 and breast carcinoma: Here we studied whether kinase activity was underlying Brk’s growth-promoting effect in human tumour xenografts and breast cancer cell sensitivity to chemotherapeutic agents in vitro and examined whether alternative splicing of Brk had any impact on patient outcomes.